These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30893842)

  • 1. The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality.
    Araújo MRP; Sa-Barreto LL; Gratieri T; Gelfuso GM; Cunha-Filho M
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30893842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magistral Compounding with 3D Printing: A Promising Way to Achieve Personalized Medicine.
    Beer N; Kaae S; Genina N; Sporrong SK; Alves TL; Hoebert J; De Bruin ML; Hegger I
    Ther Innov Regul Sci; 2023 Jan; 57(1):26-36. PubMed ID: 35943712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scenarios for 3D printing of personalized medicines - A case study.
    Beer N; Hegger I; Kaae S; De Bruin ML; Genina N; Alves TL; Hoebert J; Kälvemark Sporrong S
    Explor Res Clin Soc Pharm; 2021 Dec; 4():100073. PubMed ID: 35479838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D printed medicines: A new branch of digital healthcare.
    Awad A; Trenfield SJ; Gaisford S; Basit AW
    Int J Pharm; 2018 Sep; 548(1):586-596. PubMed ID: 30033380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex formulations, simple techniques: Can 3D printing technology be the Midas touch in pharmaceutical industry?
    Lamichhane S; Bashyal S; Keum T; Noh G; Seo JE; Bastola R; Choi J; Sohn DH; Lee S
    Asian J Pharm Sci; 2019 Sep; 14(5):465-479. PubMed ID: 32104475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D printing for drug manufacturing: A perspective on the future of pharmaceuticals.
    Lepowsky E; Tasoglu S
    Int J Bioprint; 2018; 4(1):119. PubMed ID: 33102905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
    Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing?
    Andreadis II; Gioumouxouzis CI; Eleftheriadis GK; Fatouros DG
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling.
    Melocchi A; Parietti F; Maroni A; Foppoli A; Gazzaniga A; Zema L
    Int J Pharm; 2016 Jul; 509(1-2):255-263. PubMed ID: 27215535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D Printing Technology in Pharmaceutical Dosage Forms: Advantages and Challenges.
    Desu PK; Maddiboyina B; Vanitha K; Rao Gudhanti SNK; Anusha R; Jhawat V
    Curr Drug Targets; 2021; 22(16):1901-1914. PubMed ID: 33494666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D Printing Technology: A New Milestone in the Development of Pharmaceuticals.
    Chandekar A; Mishra DK; Sharma S; Saraogi GK; Gupta U; Gupta G
    Curr Pharm Des; 2019; 25(9):937-945. PubMed ID: 31339069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D Printing Methods for Pharmaceutical Manufacturing: Opportunity and Challenges.
    Warsi MH; Yusuf M; Al Robaian M; Khan M; Muheem A; Khan S
    Curr Pharm Des; 2018; 24(42):4949-4956. PubMed ID: 30520367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D Printing Technology in Customized Drug Delivery System: Current State of the Art, Prospective and the Challenges.
    Khan FA; Narasimhan K; Swathi CSV; Mustak S; Mustafa G; Ahmad MZ; Akhter S
    Curr Pharm Des; 2018; 24(42):5049-5061. PubMed ID: 30636582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roadmap to 3D-Printed Oral Pharmaceutical Dosage Forms: Feedstock Filament Properties and Characterization for Fused Deposition Modeling.
    Aho J; Bøtker JP; Genina N; Edinger M; Arnfast L; Rantanen J
    J Pharm Sci; 2019 Jan; 108(1):26-35. PubMed ID: 30445005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D Printing Technology in Drug Delivery: Recent Progress and Application.
    Kotta S; Nair A; Alsabeelah N
    Curr Pharm Des; 2018; 24(42):5039-5048. PubMed ID: 30520368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D printing of pharmaceuticals: approach from bench scale to commercial development.
    Pawar R; Pawar A
    Futur J Pharm Sci; 2022; 8(1):48. PubMed ID: 36466365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets.
    Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW
    Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Printing technologies for drug delivery: a review.
    Prasad LK; Smyth H
    Drug Dev Ind Pharm; 2016; 42(7):1019-31. PubMed ID: 26625986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of fused deposition modeling 3D printers for pharmaceutical and medical applications.
    Feuerbach T; Kock S; Thommes M
    Pharm Dev Technol; 2018 Dec; 23(10):1136-1145. PubMed ID: 29938558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2D-3D printing in hospital pharmacies, what roles and challenges?].
    Annereau M; Toussaint B; Dufaÿ Wojcicki A; Dufaÿ S; Diaz Salmeron R; Boudy V
    Ann Pharm Fr; 2021 Jul; 79(4):361-374. PubMed ID: 33515591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.